Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.
Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial,
Introducing Oncotarget.
As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.
Publication Alerts
Subscribe to receive alerts once a paper has been published by Oncotarget.
Christoph Kahlert, Maria Fiala, Gabriel Musso, Niels Halama, Sophia Keim, Massimiliano Mazzone, Felix Lasitschka, Mathieu Pecqueux, Fee Klupp, Thomas Schmidt, Nuh Rahbari, Sebastian Schölch, Christian Pilarsky, Alexis Ulrich, Martin Schneider, Juergen Weitz, Moritz Koch
Published Dec 30, 2014 · Vol. 5, No. 24 · pp. 12978-12989
Jonathan Fallon, Robert Tighe, Giorgio Kradjian, Wilson Guzman, Anna Bernhardt, Berend Neuteboom, Yan Lan, Helen Sabzevari, Jeffrey Schlom, John W. Greiner
Published Mar 24, 2014 · Vol. 5, No. 7 · pp. 1869-1884
Samadhi Aparicio-Siegmund, Jan Sommer, Niloufar Monhasery, Ralf Schwanbeck, Eric Keil, David Finkenstädt, Klaus Pfeffer, Stefan Rose-John, Jürgen Scheller, Christoph Garbers
Published Mar 23, 2014 · Vol. 5, No. 8 · pp. 2131-2148
Hartmut Merz, Christian Kaehler, Kai P. Hoefig, Biggi Branke, Wolfgang Uckert, Roger Nadrowitz, Sabine Cerny-Reiterer, Harald Herrmann, Alfred C. Feller, Peter Valent
Published Jun 7, 2010 · Vol. 1, No. 2 · pp. 104-119